Cancer: Lymphoma-linked risk factor identified

September 25, 2013, Agency for Science, Technology and Research (A*STAR), Singapore
The 13th amino acid in the beta subunit of the HLA-DR protein, which is encoded by a gene on chromosome 6, explains part of the heritable risk of developing follicular lymphoma. Credit: iStock/Thinkstock

Follicular lymphoma is often caused by a translocation between chromosomes 14 and 18, resulting in the overexpression of a cancer-causing gene called BCL-2. A research team co-led by A*STAR scientists recently revealed another role played by genetics in this slow-growing type of blood cancer. They found that a single amino acid variation encoded by an immunity-related gene called HLA-DRB1 helps to explain why some people are at elevated risk of contracting the disease.

Since 2009, several independent research groups have shown that variants in a genomic region on the short arm of explain part of the heritable risk associated with follicular lymphoma (see image). This region contains genes that form the (HLA) system, an important mediator of immune function. However, scientists did not know the exact responsible for the lymphoma risk.

To find these variants, human geneticist Jianjun Liu and his team at the A*STAR Genome Institute of Singapore teamed up with researchers in the US and Europe. They analyzed sequences of HLA genes from 689 people with follicular lymphoma and 2,446 healthy controls from three independent population cohorts. Of all the variants tested, the strongest signal of disease linkage came from HLA-DRB1, a gene that encodes a subunit of the HLA-DR protein involved in controlling the body's T-cell responses.

In the HLA-DRB1 sequence, Liu and his co-workers identified a genetic variant at the site encoding the 13th amino acid of the resulting protein. Six amino acids naturally occur at this position. Of these, two were associated with a high risk of contracting follicular lymphoma, two were classified as low risk and two fell in between. In a comparison of disease burden, the researchers showed that people carrying two high-risk variants were 4.2 times more likely to develop follicular lymphoma than those with two variants encoding low-risk amino acids.

This information may be used to stratify individuals with higher and lower risk of developing . Most of the data, however, came from studies of European people. Thus, further work is needed to test whether it can also be used in people from Asia, notes Liu, who is now analyzing patient samples from Singapore and China. "Moreover," he says, "since this variant explains only a fraction of the risk, further studies are needed to identify additional variants and epidemiological risk factors that may be used in combination with this genetic information to provide more informative clinical risk prediction."

Explore further: Researchers discover novel DNA variants that influence risk of blood cancer

More information: Foo, J. et al. Coding variants at hexa-allelic amino acid 13 of HLA-DRB1 explain independent SNP associations with follicular lymphoma risk, The American Journal of Human Genetics 93, 167–172 (2013). dx.doi.org/10.1016/j.ajhg.2013.05.020

Related Stories

Researchers discover novel DNA variants that influence risk of blood cancer

June 27, 2013
(Medical Xpress)—Scientists at the Genome Institute of Singapore (GIS) recently led in two studies that revealed important genetic insights into the development of non-Hodgkin lymphoma (NHL). NHLs are some of the most common ...

Unraveling complex genetic interplay for MS risks

July 15, 2013
A WA-cohort of patients has been used to study the risk modifying role of specific genes suspected to contribute to one's predisposition to multiple sclerosis (MS).

Study investigates genetic variants' role in increasing Parkinson's disease risk

October 6, 2012
Boston University School of Medicine (BUSM) investigators have led the first genome-wide evaluation of genetic variants associated with Parkinson's disease (PD). The study, which is published online in PLOS ONE, points to ...

Researchers uncover new findings on genetic risks of Behçet's disease

February 15, 2013
Researchers don't know the exact cause of Behçet's disease, a chronic condition that leads to oral and genital sores and serious complications such as blindness, but new research brings better understanding to what makes ...

Fat and obesity gene also affects hip fracture

September 24, 2013
Australian researchers have demonstrated a strong association between the FTO (fat and obesity) gene and hip fracture in women. While the gene is already well known to affect diabetes and obesity, this is the first study ...

Team pinpoints amino acid variation in immune response gene linked with ulcerative colitis

December 15, 2011
The association between the inflammatory bowel disease ulcerative colitis and a gene that makes certain cell surface proteins has been pinpointed to a variant amino acid in a crucial binding site that profoundly influences ...

Recommended for you

Researchers find potential new gene therapy for blinding disease

August 20, 2018
The last year has seen milestones in the gene therapy field, with FDA approvals to treat cancer and an inherited blinding disorder. New findings from a team led by University of Pennsylvania vision scientists, who have in ...

New study explains why genetic mutations cause disease in some people but not in others

August 20, 2018
Researchers at the New York Genome Center (NYGC) and Columbia University have uncovered a molecular mechanism behind one of biology's long-standing mysteries: why individuals carrying identical gene mutations for a disease ...

Critical role of DHA on foetal brain development revealed

August 17, 2018
Duke-NUS researchers have found evidence that a natural form of Docosahexaenoic Acid (DHA) made by the liver called Lyso-Phosphatidyl-Choline (LPC-DHA), is critical for normal foetal and infant brain development, and that ...

New algorithm could improve diagnosis of rare diseases

August 17, 2018
Today, diagnosing rare genetic diseases requires a slow process of educated guesswork. Gill Bejerano, Ph.D., associate professor of developmental biology and of computer science at Stanford, is working to speed it up.

Gene silencing critical for normal breast development

August 17, 2018
Researchers have discovered that normal breast development relies on a genetic 'brake', a protein complex that keeps swathes of genes silenced.

Officials remove special rules for gene therapy experiments

August 16, 2018
U.S. health officials are eliminating special regulations for gene therapy experiments, saying that what was once exotic science is quickly becoming an established form of medical care with no extraordinary risks.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.